PP138. LACK OF ASSOCIACIATION BETWEEN FACTOR V LEIDEN MUTATION AND 20210 G/A MUTATION OF THE PROTHROMBIN GENE AND MYOCARDIAL INFARCTION IN BULGARIAN POPULATION NOSSIKOFF A., Vikentieva E., Savov A., Dimitrov S., Kremensky I., Baleva M., Denchev S.
Department of Cardiology, University Hospital Alexandrovska Laboratory of Clinical Immunology, University Hospital Alexandrovska Laboratory of Molecular Pathology, Medical University – Sofia
e-mail: alexanderbul@yahoo.com
*Corresponding Author: page: 109
|
Abstract
A total of 50 cases and 35 controls were genotyped using RFLP for the Factor V Leiden mutation and 20210 G/A prothrombin gene mutation. There were no statistically significant differences between the group of healthy controls and the group of cases with myocardial infarction. The genotypic and allelic frequencies for 20210 G/A mutation are higher (but not statistically significant) for the controls than previously reported in the literature for Bulgarian population. The genotypic and allelic frequencies for Factor V mutation both in the control and patient group are lower than previously reported in the literature for the Bulgarian population. These may be a result of the relatively small count of individuals that participated at this study. Larger studies are needed to confirm the results of our pilot study.
Factor V |
Patients with MI – 50 (100%) |
Healthy controls – 35 (100%) |
Allelic frequency |
3(3%) |
1(1,43%) |
|
c2=0.44, p=0.5 |
Genotype frequency (heterozygous genotype) |
3(6%) |
1(2.86%) |
|
c2=0.45, p=0.5 |
20210 G/A |
Patients with MI – 50(100%) |
Healthy controls – 35 (100%) |
Allelic frequency |
2(2%) |
4(5.71%) |
|
c2=1.67, p=0.20 |
Genotype frequency (heterozygous genotype) |
2(4%) |
4(11.43%) |
|
c2=1.73, p=0.18 |
|
|
|
|
|
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|